Lowell Hart to Receptor, IGF Type 1
This is a "connection" page, showing publications Lowell Hart has written about Receptor, IGF Type 1.
Connection Strength
0.124
-
Bendell JC, Jones SF, Hart L, Spigel DR, Lane CM, Earwood C, Infante JR, Barton J, Burris HA. A phase Ib study of linsitinib (OSI-906), a dual inhibitor of IGF-1R and IR tyrosine kinase, in combination with everolimus as treatment for patients with refractory metastatic colorectal cancer. Invest New Drugs. 2015 Feb; 33(1):187-93.
Score: 0.124